Insider Trading March 2, 2026

Kinsale Director Disposes 150 Shares; Transaction Totals $56,952

Director Hatcher reduces holdings while company posts stronger-than-expected Q4 results and an analyst trims its price target

By Leila Farooq KNSL
Kinsale Director Disposes 150 Shares; Transaction Totals $56,952
KNSL

A Form 4 filing shows director Hatcher Robert V. III sold 150 shares of Kinsale Capital Group, Inc. (NASDAQ:KNSL) on February 26, 2026, at $379.68 per share for a total of $56,952. The insurer's stock is trading above that sale price, and the firm recently reported quarterly results that exceeded analyst estimates even as a major bank cut its price target.

Key Points

  • Director Hatcher Robert V. III sold 150 shares of Kinsale Capital on February 26, 2026, for $379.68 per share, totaling $56,952; he now directly owns 2,097 shares.
  • Kinsale’s stock was trading at $396.18 at the time of the filing and carries a P/E ratio of 18.13 according to the cited analysis, which characterizes the stock as undervalued relative to its Fair Value assessment.
  • Kinsale reported Q4 2025 EPS of $5.81 on revenue of $483.27 million, both above analyst expectations, while BMO Capital lowered its price target to $418 from $466 and maintained a Market Perform rating due to lower growth expectations affecting underwriting and investment income.

A regulatory filing indicates that Kinsale Capital Group, Inc. (NASDAQ:KNSL) director Hatcher Robert V. III sold 150 shares on February 26, 2026. The transaction, reported on a Form 4 submitted to the Securities and Exchange Commission, lists a sale price of $379.68 per share, bringing the total proceeds to $56,952. After the sale, Hatcher directly holds 2,097 shares of the specialty insurer.

At the time of the filing, Kinsale - a specialty insurance company with a market capitalization reported at $9.2 billion - was trading at $396.18, a level above the director's sale price.


Valuation and research notes

InvestingPro analysis referenced in the filing materials indicates that KNSL is still considered undervalued relative to its Fair Value assessment. The stock is shown with a price-to-earnings ratio of 18.13, which the analysis characterizes as attractive when compared to the company’s near-term earnings growth expectations. Additional, more detailed coverage of Kinsale is available through the platform’s Pro Research Report, which covers KNSL along with more than 1,400 other U.S. equities.


Recent operating performance

Kinsale reported fourth-quarter 2025 results that outpaced consensus estimates. The company delivered earnings per share of $5.81, above the forecasted $5.26 - a 10.46% positive surprise. Revenue for the quarter was $483.27 million, materially higher than the $391.95 million that analysts had anticipated.

Despite the beat, BMO Capital lowered its price target on Kinsale to $418 from $466 while maintaining a Market Perform rating on the stock. The analyst firm said it reduced the target because of lower growth expectations that are projected to weigh on underwriting income and net investment income, citing these factors as the rationale for the adjustment.


What the filing shows - and what it does not

The Form 4 establishes the facts of the insider sale: the number of shares sold, the per-share price, the total transaction amount, and the director’s remaining direct ownership. It does not provide commentary on the director’s motivations for the sale. Separately, the company’s quarterly results and the analyst action provide context on financial performance and external expectations, but do not connect directly to the insider transaction.

Investors seeking expanded analysis can consult the referenced Pro Research Report for additional valuation details and metrics.

Risks

  • Analyst outlook - BMO Capital reduced its price target citing lower growth expectations that could pressure underwriting income and net investment income, which may affect investor returns in the insurance sector.
  • Insider sale signal - While the filing records the director's sale and remaining holdings, it does not explain the motivation, leaving uncertainty about any potential change in insider sentiment toward the company.
  • Valuation uncertainty - Despite a cited assessment that the stock is undervalued, changes in growth or income expectations noted by analysts could alter that valuation assessment over time.

More from Insider Trading

eHealth Chief Executive Increases Stake with $259,397 Purchase Mar 2, 2026 Hasbro CEO Christian P. Cocks sells $19.7 million in stock, executes options for equivalent stake Mar 2, 2026 SoFi CEO Anthony Noto Buys $1.0 Million of Stock Amid Weak Share Performance Mar 2, 2026 Republic Bancorp Director Sells $74,165 in Class A Shares as Bank Ups Dividend Mar 2, 2026 Standex director disposes of $133,380 in shares as stock trades near 52-week high Mar 2, 2026